Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 7
Results: 27
In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Specialty Differences in Medical Aid in Dying Experiences: Results of a Survey of Physicians in Colorado.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e585, doi. 10.1093/oncolo/oyad131
- By:
- Publication type:
- Article
Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 575, doi. 10.1093/oncolo/oyad126
- By:
- Publication type:
- Article
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 565, doi. 10.1093/oncolo/oyad123
- By:
- Publication type:
- Article
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e534, doi. 10.1093/oncolo/oyad122
- By:
- Publication type:
- Article
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 628, doi. 10.1093/oncolo/oyad119
- By:
- Publication type:
- Article
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 555, doi. 10.1093/oncolo/oyad116
- By:
- Publication type:
- Article
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 644, doi. 10.1093/oncolo/oyad106
- By:
- Publication type:
- Article
Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 624, doi. 10.1093/oncolo/oyad105
- By:
- Publication type:
- Article
Race/Ethnicity and Gender Representation in Hematology and Oncology Editorial Boards: What is the State of Diversity?
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 609, doi. 10.1093/oncolo/oyad103
- By:
- Publication type:
- Article
Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 596, doi. 10.1093/oncolo/oyad102
- By:
- Publication type:
- Article
Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e493, doi. 10.1093/oncolo/oyad092
- By:
- Publication type:
- Article
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e526, doi. 10.1093/oncolo/oyad090
- By:
- Publication type:
- Article
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 618, doi. 10.1093/oncolo/oyad085
- By:
- Publication type:
- Article
Management of Patients With Pancreatic Cancer Using the "Right Track" Model.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 584, doi. 10.1093/oncolo/oyad080
- By:
- Publication type:
- Article
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 633, doi. 10.1093/oncolo/oyad076
- By:
- Publication type:
- Article
A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e520, doi. 10.1093/oncolo/oyad075
- By:
- Publication type:
- Article
Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television Advertising.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e542, doi. 10.1093/oncolo/oyad064
- By:
- Publication type:
- Article
Patient Characteristics Associated With Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 604, doi. 10.1093/oncolo/oyad062
- By:
- Publication type:
- Article
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e508, doi. 10.1093/oncolo/oyad040
- By:
- Publication type:
- Article
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 640, doi. 10.1093/oncolo/oyad029
- By:
- Publication type:
- Article
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e498, doi. 10.1093/oncolo/oyad026
- By:
- Publication type:
- Article
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e488, doi. 10.1093/oncolo/oyad024
- By:
- Publication type:
- Article
A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e575, doi. 10.1093/oncolo/oyac146
- By:
- Publication type:
- Article
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
- By:
- Publication type:
- Article